TY - JOUR
T1 - Early and extensive alterations of glial connexins, distal oligodendrogliopathy type demyelination, and nodal/paranodal pathology are characteristic of multiple system atrophy
AU - Nishimura, Yuji
AU - Masaki, Katsuhisa
AU - Matsuse, Dai
AU - Yamaguchi, Hiroo
AU - Tanaka, Tatsunori
AU - Matsuo, Eriko
AU - Hayashida, Shotaro
AU - Watanabe, Mitsuru
AU - Matsushita, Takuya
AU - Sadashima, Shoko
AU - Sasagasako, Naokazu
AU - Yamasaki, Ryo
AU - Isobe, Noriko
AU - Iwaki, Toru
AU - Kira, Jun ichi
N1 - Funding Information:
This study was supported in part by a JSPS KAKENHI Grant‐in‐Aid for Challenging Research (Pioneering) (Grant number 19H05562) (J.K.) and Grants‐in‐Aid for Scientific Research (A) (Grant Number 19H01045) (J.K.), (C) (Grant Number 20K07889) (K.M.), (C) (Grant Number 19K07976) (H.Y.), (C) (Grant Number 21K07438) (D.M.), and (C) (Grant Number 21K07464) (N.I.) from the Japan Society for the Promotion of Science, and by a Grant from the Japan Agency for Medical Research and Development (AMED) Moonshot Research & Development Program (Grant Number JP21zf0127004) (N.I.). We thank Mr. Takaaki Kanemaru, Morphology Core Unit, Kyushu University (Japan), for excellent technical assistance. We also thank Ms. Sachiko Koyama and Hideko Noguchi, Department of Neuropathology, Kyushu University (Japan) for their technical assistance. We thank Associate Professor Junji Kishimoto and Drs. Masayuki Hirose and Koshiro Tagawa, Kyushu University Hospital ARO Next Generation Medical Center (Japan) for their assistance with statistical methods. Finally, we thank Lisa Kreiner, PhD, and Bronwen Gardner, PhD, from Edanz ( https://jp.edanz.com/ac ) for editing a draft of this manuscript.
Funding Information:
Grants‐in‐Aid for Scientific Research, Grant/Award Numbers: 21K07464, 21K07438, 19K07976, 20K07889, 19H01045; Japan Society for the Promotion of Science, Grant/Award Number: 19H05562; Japan Agency for Medical Research and Development (AMED) Moonshot Research & Development Program, Grant/Award Number: JP21zf0127004 Funding information
Publisher Copyright:
© 2022 The Authors. Brain Pathology published by John Wiley & Sons Ltd on behalf of International Society of Neuropathology.
PY - 2022
Y1 - 2022
N2 - The pathological hallmark of multiple system atrophy (MSA) is aberrant accumulation of phosphorylated α-synuclein in oligodendrocytes, forming glial cytoplasmic inclusions (GCIs). Extensive demyelination occurs particularly in the olivopontocerebellar and striatonigral pathways, but its precise mechanism remains elusive. Glial connexins (Cxs), which form gap junction channels between astrocytes and oligodendrocytes, play critical roles in myelin maintenance, and have not been studied in MSA. Therefore, we immunohistochemically investigated glial Cx changes in the cerebellar afferent fibers in 15 autopsied patients with MSA. We classified demyelinating lesions into three stages based on Klüver–Barrera staining: early (Stage I), intermediate (Stage II), and late (Stage III) stages showing subtle, moderate, and severe myelin reduction, respectively. Myelin-associated glycoprotein, but not myelin oligodendrocyte glycoprotein, was preferentially decreased in Stage I, suggesting distal oligodendrogliopathy type demyelination. Accumulation of phosphorylated α-synuclein in oligodendrocytes was frequently seen in Stage I but less frequently observed in Stages II and III. Tubulin polymerization-promoting protein (TPPP/p25α)-positive oligodendrocytes were preserved in Stage I but successively decreased in Stages II and III. Even at Stage I, Cx32 was nearly absent from myelin, despite the relative preservation of other nodal proteins, such as neurofascin, claudin-11/oligodendrocyte-specific protein, and contactin-associated protein 1, which successively decreased in the later stages. Cx32 was re-distributed in the oligodendrocyte cytoplasm and co-localized with GCIs. Cx47 gradually decreased at the oligodendrocyte surface in a stage-dependent manner but was not co-localized with GCIs. Astrocytic Cx43 was down-regulated in Stage I but up-regulated in Stages II and III, reflecting astrogliosis. Cx43/Cx47 gap junctions significantly decreased from Stage I to III. Activated microglia/macrophages and T cells infiltrated in Stage I rather than Stages II and III. Therefore, early and extensive alterations of glial Cxs, particularly Cx32 loss, occur in MSA and may accelerate distal oligodendrogliopathy type demyelination and nodal/paranodal dysfunction through disruption of inter-glial communication.
AB - The pathological hallmark of multiple system atrophy (MSA) is aberrant accumulation of phosphorylated α-synuclein in oligodendrocytes, forming glial cytoplasmic inclusions (GCIs). Extensive demyelination occurs particularly in the olivopontocerebellar and striatonigral pathways, but its precise mechanism remains elusive. Glial connexins (Cxs), which form gap junction channels between astrocytes and oligodendrocytes, play critical roles in myelin maintenance, and have not been studied in MSA. Therefore, we immunohistochemically investigated glial Cx changes in the cerebellar afferent fibers in 15 autopsied patients with MSA. We classified demyelinating lesions into three stages based on Klüver–Barrera staining: early (Stage I), intermediate (Stage II), and late (Stage III) stages showing subtle, moderate, and severe myelin reduction, respectively. Myelin-associated glycoprotein, but not myelin oligodendrocyte glycoprotein, was preferentially decreased in Stage I, suggesting distal oligodendrogliopathy type demyelination. Accumulation of phosphorylated α-synuclein in oligodendrocytes was frequently seen in Stage I but less frequently observed in Stages II and III. Tubulin polymerization-promoting protein (TPPP/p25α)-positive oligodendrocytes were preserved in Stage I but successively decreased in Stages II and III. Even at Stage I, Cx32 was nearly absent from myelin, despite the relative preservation of other nodal proteins, such as neurofascin, claudin-11/oligodendrocyte-specific protein, and contactin-associated protein 1, which successively decreased in the later stages. Cx32 was re-distributed in the oligodendrocyte cytoplasm and co-localized with GCIs. Cx47 gradually decreased at the oligodendrocyte surface in a stage-dependent manner but was not co-localized with GCIs. Astrocytic Cx43 was down-regulated in Stage I but up-regulated in Stages II and III, reflecting astrogliosis. Cx43/Cx47 gap junctions significantly decreased from Stage I to III. Activated microglia/macrophages and T cells infiltrated in Stage I rather than Stages II and III. Therefore, early and extensive alterations of glial Cxs, particularly Cx32 loss, occur in MSA and may accelerate distal oligodendrogliopathy type demyelination and nodal/paranodal dysfunction through disruption of inter-glial communication.
UR - http://www.scopus.com/inward/record.url?scp=85141943156&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85141943156&partnerID=8YFLogxK
U2 - 10.1111/bpa.13131
DO - 10.1111/bpa.13131
M3 - Article
C2 - 36368713
AN - SCOPUS:85141943156
SN - 1015-6305
JO - Brain Pathology
JF - Brain Pathology
ER -